[EN] INHIBITORS OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA FORMATION AND THEIR METHOD OF USE [FR] INHIBITEURS D'UNE FORMATION D'ADN CIRCULAIRE FERMÉE DE FAÇON COVALENTE DU VIRUS DE L'HÉPATITE B ET LEUR PROCÉDÉ D'UTILISATION
[EN] INHIBITORS OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA FORMATION AND THEIR METHOD OF USE [FR] INHIBITEURS D'UNE FORMATION D'ADN CIRCULAIRE FERMÉE DE FAÇON COVALENTE DU VIRUS DE L'HÉPATITE B ET LEUR PROCÉDÉ D'UTILISATION
Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
申请人:Li Xiaodong
公开号:US20090274632A1
公开(公告)日:2009-11-05
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.
[EN] SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS<br/>[FR] PYRAZOLOAZÉPIN-4-ONES SUBSTITUÉES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PHOSPHODIESTÉRASE
申请人:LEO PHARMA AS
公开号:WO2018108230A1
公开(公告)日:2018-06-21
The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Compounds that inhibit (block) bitter taste in composition and methods of making same
申请人:LI Xiaodong
公开号:US20110207937A1
公开(公告)日:2011-08-25
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.
COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITION AND USE THEREOF
申请人:KARANEWSKY Donald S.
公开号:US20120088796A1
公开(公告)日:2012-04-12
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.
Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
申请人:Karanewsky Donald S.
公开号:US20100254916A1
公开(公告)日:2010-10-07
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.